Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	LIK066 2.5mg qd	0	19
Total, all-cause mortality	LIK066 10mg qd	0	19
Total, all-cause mortality	LIK066 25mg qd	0	28
Total, all-cause mortality	LIK066 50mg qd	0	31
Total, all-cause mortality	Placebo	0	29
Total, other adverse events	LIK066 2.5mg qd	10	19
Total, other adverse events	LIK066 10mg qd	12	19
Total, other adverse events	LIK066 25mg qd	13	28
Total, other adverse events	LIK066 50mg qd	20	31
Total, other adverse events	Placebo	9	29
Total, serious adverse events	LIK066 2.5mg qd	0	19
Total, serious adverse events	LIK066 10mg qd	0	19
Total, serious adverse events	LIK066 25mg qd	0	28
Total, serious adverse events	LIK066 50mg qd	1	31
Total, serious adverse events	Placebo	0	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03320941/event-totals